Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection

Abstract Background Coronavirus disease 2019 (COVID-19) is a global pandemic with no licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics of SARS-CoV-2-specific neutralizing antibodies (NAbs) in COVID-19 patients. Methods Blood samples (n=173) […]

Click here to view original web page at Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection